Phase Ia

Related by string. * phase . phases . Phases . PHASE . PHASES : Phase III clinical trials . Phase III clinical . Phase III trials . Phase 2b clinical . pivotal Phase III . ongoing Phase 1b . Phase III Clinical Trial . knockout phase / iAd . ia . IAS . IAD . IAs . iA . ias : Cedar Rapids IA . Cedar Rapids Ia . SIOUX CITY IA . CEDAR RAPIDS IA . Davenport IA . Des Moines IA . batch IAS officer * Phase Ia Ib *

Related by context. Frequent words. (Click for all words.) 77 Phase Ib 76 Phase 1b clinical 75 Phase IIa clinical 74 Phase 2a clinical 74 Phase 2b study 74 Phase 2a trial 73 single ascending dose 73 multiple ascending dose 73 phase IIb 72 Phase 2a 72 Phase 1b 72 Phase IIa trial 71 Phase III clinical 71 dose escalation trial 71 Phase IIb clinical 70 Phase 2b trial 70 Phase IIa 70 phase 2a 69 Phase III 69 Phase IIb 69 Phase 2b 68 Phase 2b clinical 68 Phase IIb trial 68 pivotal Phase III 67 dose escalation study 66 Phase II 66 randomized Phase 65 placebo controlled 65 clinical trial 64 blinded placebo controlled 63 ISIS # 63 pharmacokinetic 63 Phase III clinical trials 63 IND enabling 63 confirmatory Phase 3 62 Phase III pivotal 62 PRX # 62 PXD# 62 randomized placebo controlled 62 CoFactor 62 pivotal Phase 62 Phase 62 HGS ETR1 62 pharmacodynamics 62 dose escalation 61 HspE7 61 randomized controlled 61 multicenter randomized double 61 PS# [001] 61 ARRY 61 randomized clinical 61 Board DSMB 61 NGX# 61 Phase III trials 60 IMGN# 60 blind randomized placebo 60 clinical trials 60 double blind placebo 60 tolerated dose MTD 60 preclinical 60 tolerability 60 safety tolerability 60 randomized double 59 investigational drug 59 pharmacokinetics 59 ALTU 59 MDV# 59 immunogenicity 59 IDX# 59 blinatumomab 59 unblinded 59 RDEA# 59 voreloxin 59 pharmacokinetic profile 59 initiate Phase 59 VEGF Trap 59 CRx 59 CTCE 58 preclinical studies 58 AP# [003] 58 DSMB 58 ALN RSV# 58 Zerenex 58 Alpharadin 58 ALN VSP 58 oral formulation 58 Menerba 58 PEG Interferon lambda 58 AEZS 58 INCB# [002] 58 RG# [001] 58 CA4P 58 Marqibo 58 DB# [003] 58 mipomersen 58 elagolix 58 efficacy endpoints 58 pegloticase 58 randomized controlled clinical 57 tgAAC# 57 tolerability profile

Back to home page